Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study.
drug and substance misuse
heroin
patient perspectives
pulmonary disease, chronic obstructive
smoking
Journal
BJGP open
ISSN: 2398-3795
Titre abrégé: BJGP Open
Pays: England
ID NLM: 101713531
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
11
12
2019
accepted:
02
02
2020
pubmed:
16
7
2020
medline:
16
7
2020
entrez:
16
7
2020
Statut:
epublish
Résumé
Smoking rather than injecting heroin has become more common over the last 20 years. Although there is an increasing body of evidence describing high levels of chronic obstructive pulmonary disease (COPD) in people who smoke heroin, there is limited evidence documenting the impact of the long-term condition on this population group. This study aimed to describe the experiences of people who smoke heroin with COPD in Liverpool, UK. Participants were purposefully sampled for this qualitative study. They included adults enrolled in an opioid replacement clinic run by Addaction in Liverpool, who had already engaged with spirometry testing for COPD as part of a previous study. Semi-structured interviews were performed with participants with spirometrically confirmed COPD in opioid replacement clinics. Data were analysed using a framework analysis approach. Sixteen potential participants were invited to take part in the study, of which 10 agreed and were interviewed. Three themes common to all interviews were identified: functional measures of lung health that impacted on their activities of daily living; inhaler and medication perceptions with erratic use that was not concordant with their prescription; and the impact of difficulties accessing care. These findings, along with previous studies highlighting the prevalence of COPD in this population, warrant efforts to integrate community COPD and opioid replacement services to improve outcomes for this vulnerable population.
Sections du résumé
BACKGROUND
BACKGROUND
Smoking rather than injecting heroin has become more common over the last 20 years. Although there is an increasing body of evidence describing high levels of chronic obstructive pulmonary disease (COPD) in people who smoke heroin, there is limited evidence documenting the impact of the long-term condition on this population group.
AIM
OBJECTIVE
This study aimed to describe the experiences of people who smoke heroin with COPD in Liverpool, UK.
DESIGN & SETTING
METHODS
Participants were purposefully sampled for this qualitative study. They included adults enrolled in an opioid replacement clinic run by Addaction in Liverpool, who had already engaged with spirometry testing for COPD as part of a previous study.
METHOD
METHODS
Semi-structured interviews were performed with participants with spirometrically confirmed COPD in opioid replacement clinics. Data were analysed using a framework analysis approach.
RESULTS
RESULTS
Sixteen potential participants were invited to take part in the study, of which 10 agreed and were interviewed. Three themes common to all interviews were identified: functional measures of lung health that impacted on their activities of daily living; inhaler and medication perceptions with erratic use that was not concordant with their prescription; and the impact of difficulties accessing care.
CONCLUSION
CONCLUSIONS
These findings, along with previous studies highlighting the prevalence of COPD in this population, warrant efforts to integrate community COPD and opioid replacement services to improve outcomes for this vulnerable population.
Identifiants
pubmed: 32665233
pii: bjgpopen20X101055
doi: 10.3399/bjgpopen20X101055
pmc: PMC7465580
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2020, The Authors.
Références
Drug Alcohol Depend. 2002 Oct 1;68(2):221-8
pubmed: 12234652
Addiction. 1999 Jan;94(1):71-82
pubmed: 10665099
J Adv Nurs. 2013 Apr;69(4):935-46
pubmed: 22776007
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
J Am Med Dir Assoc. 2012 Mar;13(3):284-90
pubmed: 21450242
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
pubmed: 17507545
Chest. 2006 Jul;130(1):133-42
pubmed: 16840393
Harm Reduct J. 2014 Jun 27;11:18
pubmed: 24973031
Eur J Clin Pharmacol. 2012 Oct;68(10):1365-73
pubmed: 22476392
Health Soc Care Community. 2008 Mar;16(2):147-54
pubmed: 18290980
Lung. 2014 Oct;192(5):669-73
pubmed: 25097097
Chest. 2019 Feb;155(2):247-248
pubmed: 30732683
Harm Reduct J. 2008 Jul 21;5:24
pubmed: 18644143
Addiction. 2007 Jun;102(6):958-69
pubmed: 17523991
Chest. 2019 Feb;155(2):279-287
pubmed: 30189189
Br J Addict. 1991 Sep;86(9):1091-7
pubmed: 1932880
Thorax. 2008 Sep;63(9):831-8
pubmed: 18728206
Addiction. 2019 May;114(5):868-876
pubmed: 30675957
COPD. 2016 Jun;13(3):333-8
pubmed: 26701201
Addict Behav. 2005 Aug;30(7):1342-50
pubmed: 16022931
Chest. 2020 Mar;157(3):558-565
pubmed: 31759961